MetaCap

CalciMedica (CALC) vs Optimi Health (OPTH)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

CalciMedica is the larger company by market cap ($8.7 million vs $8.6 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CALC-60.93%OPTH-75.16%
+71%-5%-82%
May 20, 20261 yearNov 20, 2026
CALC-59.94%OPTH-74.19%
+76%-3%-81%
May 18, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CALC versus OPTH key metrics
MetricCALCOPTH
Share price$1.26$1.51
Market cap$8.69M$8.65M
1-day change+7.69%-13.71%
YTD return-96.18%—
1-year return-92.34%—
EPS (TTM)$-4.41$-1.56
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-29.56M—
52-week high$36.00$6.40
52-week low$1.00$1.51
Distance from 52-week high-96.50%-76.41%
Analyst consensusnone—
Avg. price target upside+3868.25%—
Average volume80.15K43.55K
Shares outstanding6.90M5.73M
Employees15—
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About CalciMedica

CALC stock →

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia.

Health Care · Biotechnology: Pharmaceutical Preparations · 15 employees

About Optimi Health

OPTH stock →

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.

Health Care · Biotechnology: Pharmaceutical Preparations

CALC vs OPTH FAQ

Which is bigger, CalciMedica or Optimi Health?

CalciMedica (CALC) is larger, with a market capitalization of $8.69M compared with $8.65M for Optimi Health (OPTH).

Are CalciMedica and Optimi Health in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons